These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2010-019552-50 Dose-escalation-, PK- and safety study with single agent CetuGEXTM in patients with EGFR positive locally advanced and/or metastatic cancer 2013-11-14 due-trials
Not reported 2012-003006-27 A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX™ in Comparison With 150 IU Gonal-f® in Women Undergoing IC... 2013-07-30 due-trials
Listed as ongoing, but also has a completion date 2013-000931-28 A Double-blind, Placebo-controlled, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of Maintenance Therapy With PankoMab-GEX™ After Chemotherapy in Patients With Recurrent Epithelial Ova... 2017-08-15 bad-data
Not reported 2013-003695-13 Randomized, controlled, open label, multicenter, phase II study to evaluate the efficacy and safety of CetuGEX™ plus chemotherapy in comparison to cetuximab plus chemotherapy for the treatment of pati... 2017-09-30 due-trials